Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Multiscale Modeling in the Clinic: Drug Design and Development

Open access

Abstract

A wide range of length and time scales are relevant to pharmacology, especially in drug development, drug design and drug delivery. Therefore, multiscale computational modeling and simulation methods and paradigms that advance the linkage of phenomena occurring at these multiple scales have become increasingly important. Multiscale approaches present in silico opportunities to advance laboratory research to bedside clinical applications in pharmaceuticals research. This is achievable through the capability of modeling to reveal phenomena occurring across multiple spatial and temporal scales, which are not otherwise readily accessible to experimentation. The resultant models, when validated, are capable of making testable predictions to guide drug design and delivery. In this review we describe the goals, methods, and opportunities of multiscale modeling in drug design and development. We demonstrate the impact of multiple scales of modeling in this field. We indicate the common mathematical and computational techniques employed for multiscale modeling approaches used in pharmacometric and systems pharmacology models in drug development and present several examples illustrating the current state-of-the-art models for (1) excitable systems and applications in cardiac disease; (2) stem cell driven complex biosystems; (3) nanoparticle delivery, with applications to angiogenesis and cancer therapy; (4) host-pathogen interactions and their use in metabolic disorders, inflammation and sepsis; and (5) computer-aided design of nanomedical systems. We conclude with a focus on barriers to successful clinical translation of drug development, drug design and drug delivery multiscale models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10439-016-1563-0

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 141 · Cited by 62

Research works printed but not linked: 1

  1. Sorger, P. K. et al. Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms. An NIH White Paper by the QSP Workshop Group. (2011). https://www.nigms.nih.gov/training/documents/systemspharmawpsorger2011.pdf .

Metadata

Authors
Clancy, C. E., An, G., Cannon, W. R., Liu, Y., May, E. E., Ortoleva, P., Popel, A. S., Sluka, J. P., Su, J., Vicini, P., Zhou, X., & Eckmann, D. M.
Affiliations
  • University of California, Davis (US)
  • University of Chicago (US)
  • Pacific Northwest National Laboratory (US)
  • Lehigh University (US)
  • University of Houston (US)
  • Indiana University Bloomington (US)
  • Johns Hopkins University (US)
  • Wake Forest University Health Sciences (US)
  • University of Pennsylvania (US)
Corresponding author
  • Clancy, Colleen E.
  • Eckmann, David M.
Venue
Annals of Biomedical Engineering
Published
2016-02-17
Volume
44
Issue
9
Pages
2591-2610
ISSN
  • 0090-6964 (ISSN-L)
  • 1573-9686
OpenAlex
W2287937249
Cited by
62
References
141
Citations by year
2026: 5 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 10 · 2019: 5 · 2018: 7 · 2017: 2 · 2016: 5
FWCI
5.83
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of Biomedical Engineering (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (R01CA138264, U01HL126273, R01EB006818, R01GM077138, R01GM115839, P30DK42086, U01EB016027, R15EB015105)
  • U.S. Environmental Protection Agency (R835001)
  • U.S. Department of Energy (DE- AC06-76RLO)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Physical Sciences › Mathematics › Applied Mathematics › Advanced Mathematical Modeling in Engineering
Keywords
multiscale modeling, drug design, drug development, drug delivery, systems pharmacology, pharmacometrics, nanoparticle delivery, angiogenesis, cancer therapy, host-pathogen interaction, metabolic disorders, inflammation, sepsis, nanomedicine, clinical translation
MeSH terms
Animals, Computer Simulation, Humans, Models, Theoretical, Drug Design, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiscale Modeling in the Clinic: Drug Design and Development. https://app.cochat.ai/papers/10.1007/s10439-016-1563-0
The paper
Clancy, C. E., An, G., Cannon, W. R., Liu, Y., May, E. E., Ortoleva, P., Popel, A. S., Sluka, J. P., Su, J., Vicini, P., Zhou, X., & Eckmann, D. M. (2016). Multiscale Modeling in the Clinic: Drug Design and Development. Annals of Biomedical Engineering. https://doi.org/10.1007/s10439-016-1563-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.